Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2024. The report specifically details a transaction in own shares executed on September 4, 2024, under a share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 293,991 ordinary shares
- Highest Price Paid: 386.00 pence per share
- Lowest Price Paid: 381.50 pence per share
- Volume Weighted Average Price: 383.7611 pence per share
- Post-Transaction Share Capital: 9,122,817,072 ordinary shares
Material Changes
The primary material change is the reduction of the company's registered share capital following the cancellation of the 293,991 shares purchased. No other material changes to financial position or operations are disclosed in this specific filing.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies. It serves strictly as a regulatory disclosure of a completed share transaction in compliance with the Market Abuse Regulation.
Key Facts for Investor Verification
- Verify the total number of shares repurchased to date under the August 2024 Buyback Programme.
- Confirm the updated total share capital of 9,122,817,072 shares for disclosure threshold calculations.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular transaction data.